ACXP logo

Acurx Pharmaceuticals, Inc. Common Stock


ACXP: Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.


Show ACXP Financials

Consumer Interest
SEC Filings

Recent trades of ACXP by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quiver Logo

No Whale Activity for this ticker

Institutional Holdings Dashboard

Quarterly net insider trading by ACXP's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Dna polymerase iiic inhibitors and use thereof May. 11, 2021
  • Patent Title: Dna polymerase iiic inhibitors and use thereof Nov. 17, 2020
  • Patent Title: Dna polymerase iiic inhibitors and use thereof Jul. 28, 2020
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of ACXP in WallStreetBets Daily Discussion


Recent insights relating to ACXP

CNBC Recommendations

Recent picks made for ACXP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in ACXP

Corporate Flights

Flights by private jets registered to ACXP